Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,554,645
  • Shares Outstanding, K 106,045
  • Annual Sales, $ 675,040 K
  • Annual Income, $ 141,210 K
  • EBIT $ 111 M
  • EBITDA $ 101 M
  • 60-Month Beta 0.19
  • Price/Sales 11.29
  • Price/Cash Flow 57.85
  • Price/Book 11.15

Options Overview Details

View History
  • Implied Volatility 55.66% ( -5.84%)
  • Historical Volatility 35.17%
  • IV Percentile 21%
  • IV Rank 45.42%
  • IV High 105.97% on 02/28/25
  • IV Low 13.78% on 08/16/24
  • Put/Call Vol Ratio 0.52
  • Today's Volume 221
  • Volume Avg (30-Day) 1,665
  • Put/Call OI Ratio 1.15
  • Today's Open Interest 45,008
  • Open Int (30-Day) 40,077

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.23
  • Number of Estimates 4
  • High Estimate 0.30
  • Low Estimate 0.08
  • Prior Year 0.32
  • Growth Rate Est. (year over year) -28.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.50 +7.14%
on 06/03/25
86.20 -17.35%
on 06/02/25
-3.84 (-5.11%)
since 05/16/25
3-Month
53.79 +32.44%
on 03/28/25
117.33 -39.28%
on 03/31/25
+14.74 (+26.09%)
since 03/18/25
52-Week
28.10 +153.52%
on 06/20/24
117.33 -39.28%
on 03/31/25
+43.09 (+153.07%)
since 06/18/24

Most Recent Stories

More News
1 Small-Cap Stock Worth Your Attention and 2 to Question

1 Small-Cap Stock Worth Your Attention and 2 to Question

CORT : 71.24 (-0.85%)
AWI : 151.33 (+0.58%)
WMS : 113.00 (-0.51%)
Corcept: Q1 Earnings Snapshot

Corcept: Q1 Earnings Snapshot

CORT : 71.24 (-0.85%)
3 Healthcare Stocks That Concern Us

3 Healthcare Stocks That Concern Us

CORT : 71.24 (-0.85%)
COLL : 29.60 (+0.54%)
SEM : 14.92 (+1.29%)
SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know

SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know

CORT : 71.24 (-0.85%)
SOUN : 9.42 (+0.86%)
PLUG : 1.1400 (+4.59%)
DOMO : 12.63 (-3.44%)
EGHT : 1.8400 (unch)
3 Biopharmaceutical Stocks Bucking the Sell-Off

Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.

CORT : 71.24 (-0.85%)
DBVT : 9.85 (+4.01%)
SLRN : 2.27 (+1.79%)
ABBV : 185.49 (+0.01%)
ALMS : 3.01 (unch)
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

CORT : 71.24 (-0.85%)
SUPN : 32.96 (+1.96%)
LLY : 785.03 (-0.78%)
ZTS : 155.06 (-4.09%)
BMY : 46.84 (-0.83%)
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

CORT : 71.24 (-0.85%)
OGN : 9.88 (+0.30%)
SUPN : 32.96 (+1.96%)
MRK : 79.29 (+1.29%)
ZTS : 155.06 (-4.09%)
SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Sanofi SNY and partner, Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia (fitusiran) as the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce...

BAYRY : 7.7700 (+0.78%)
CORT : 71.24 (-0.85%)
ALNY : 312.32 (+1.17%)
SNY : 47.62 (-1.24%)
Why Is Corcept (CORT) Stock Soaring Today

Why Is Corcept (CORT) Stock Soaring Today

CORT : 71.24 (-0.85%)
3 Reasons to Sell CORT and 1 Stock to Buy Instead

3 Reasons to Sell CORT and 1 Stock to Buy Instead

CORT : 71.24 (-0.85%)
TDG : 1,414.48 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 75.00
2nd Resistance Point 74.06
1st Resistance Point 72.65
Last Price 71.24
1st Support Level 70.31
2nd Support Level 69.37
3rd Support Level 67.96

See More

52-Week High 117.33
Fibonacci 61.8% 83.24
Fibonacci 50% 72.72
Last Price 71.24
Fibonacci 38.2% 62.19
52-Week Low 28.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar